Edgewood Management’s Pfizer PFE Stock Holding History

Edgewood Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Hold	82,179	–	–	0.02%	57
2026 Q1	$2.31M	Hold	82,179	–	–	0.01%	48
2025 Q4	$2.05M	Hold	82,179	–	–	0.01%	55
2025 Q3	$2.09M	Sell	82,179 -2,732	-3%	-$67.4K	0.01%	51
2025 Q2	$2.06M	Hold	84,911	–	–	0.01%	50
2025 Q1	$2.15M	Hold	84,911	–	–	0.01%	53
2024 Q4	$2.25M	Hold	84,911	–	–	0.01%	52
2024 Q3	$2.46M	Hold	84,911	–	–	0.01%	47
2024 Q2	$2.38M	Hold	84,911	–	–	0.01%	49
2024 Q1	$2.36M	Hold	84,911	–	–	0.01%	46
2023 Q4	$2.44M	Hold	84,911	–	–	0.01%	44
2023 Q3	$2.82M	Hold	84,911	–	–	0.01%	43
2023 Q2	$3.11M	Hold	84,911	–	–	0.01%	42
2023 Q1	$3.46M	Hold	84,911	–	–	0.01%	39
2022 Q4	$4.35M	Hold	84,911	–	–	0.02%	38
2022 Q3	$3.72M	Hold	84,911	–	–	0.01%	35
2022 Q2	$4.45M	Hold	84,911	–	–	0.01%	37
2022 Q1	$4.4M	Hold	84,911	–	–	0.01%	35
2021 Q4	$5.01M	Hold	84,911	–	–	0.01%	37
2021 Q3	$3.65M	Hold	84,911	–	–	0.01%	38
2021 Q2	$3.33M	Sell	84,911 -1,817	-2%	-$70.7K	0.01%	38
2021 Q1	$3.14M	Hold	86,728	–	–	0.01%	41
2020 Q4	$3.19M	Sell	86,728 -4,683	-5%	-$172K	0.01%	39
2020 Q3	$3.18M	Hold	91,411	–	–	0.01%	40
2020 Q2	$2.84M	Hold	91,411	–	–	0.01%	39
2020 Q1	$2.83M	Hold	91,411	–	–	0.01%	38
2019 Q4	$3.4M	Sell	91,411 -7,184	-7%	-$256K	0.01%	38
2019 Q3	$3.36M	Hold	98,595	–	–	0.01%	38
2019 Q2	$4.05M	Hold	98,595	–	–	0.01%	35
2019 Q1	$3.97M	Sell	98,595 -2,485	-2%	-$99.5K	0.01%	36
2018 Q4	$4.19M	Sell	101,080 -1,147	-1%	-$47.6K	0.02%	37
2018 Q3	$4.27M	Hold	102,227	–	–	0.01%	35
2018 Q2	$3.52M	Hold	102,227	–	–	0.01%	36
2018 Q1	$3.44M	Hold	102,227	–	–	0.01%	35
2017 Q4	$3.51M	Hold	102,227	–	–	0.02%	37
2017 Q3	$3.46M	Sell	102,227 -4,006	-4%	-$129K	0.02%	37
2017 Q2	$3.39M	Hold	106,233	–	–	0.02%	37
2017 Q1	$3.45M	Hold	106,233	–	–	0.02%	37
2016 Q4	$3.27M	Sell	106,233 -4,969	-4%	-$152K	0.02%	38
2016 Q3	$3.57M	Hold	111,202	–	–	0.02%	35
2016 Q2	$3.71M	Sell	111,202 -527	-0.5%	-$16.8K	0.03%	34
2016 Q1	$3.14M	Sell	111,729 -2,424	-2%	-$69.2K	0.02%	36
2015 Q4	$3.5M	Hold	114,153	–	–	0.03%	38
2015 Q3	$3.4M	Sell	114,153 -3,345	-3%	-$107K	0.03%	36
2015 Q2	$3.74M	Sell	117,498 -411	-0.3%	-$13.4K	0.03%	34
2015 Q1	$3.89M	Sell	117,909 -106	-0.1%	-$3.37K	0.03%	35
2014 Q4	$3.49M	Hold	118,015	–	–	0.03%	36
2014 Q3	$3.31M	Hold	118,015	–	–	0.03%	35
2014 Q2	$3.32M	Sell	118,015 -7,973	-6%	-$227K	0.03%	36
2014 Q1	$3.84M	Hold	125,988	–	–	0.04%	35
2013 Q4	$3.66M	Sell	125,988 -1,054	-0.8%	-$30.7K	0.04%	36
2013 Q3	$3.46M	Hold	127,042	–	–	0.04%	35
2013 Q2	$3.38M	Buy	+127,042	New	+$3.51M	0.05%	33

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Edgewood Management's PFE Position: Q2 2026 in Review

Edgewood Management held its Pfizer (PFE) position steady in Q2 2026 at 82,179 shares worth $1.98M. The position accounts for 0.02% of the portfolio, ranked #57.

Edgewood Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.01M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Edgewood Management held 82,179 shares of Pfizer worth $1.98M as of Q2 2026.
Edgewood Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.02% of Edgewood Management's portfolio in Q2 2026, its #57 holding.
Edgewood Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Edgewood Management's Pfizer position peaked at $5.01M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Edgewood Management's 13F filing for Q2 2026, filed 13 Aug 2026.